OLVAC A+G
OLVAC A+G
Authorised
- Infectious bursal disease virus, Inactivated
- Eggdrop syndrome-1976 virus, Inactivated
- Newcastle disease virus, Inactivated
Product identification
Medicine name:
OLVAC A+G
Active substance:
- Infectious bursal disease virus, Inactivated
- Eggdrop syndrome-1976 virus, Inactivated
- Newcastle disease virus, Inactivated
Target species:
-
Chicken (layer hen)
-
Chicken (for reproduction)
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Infectious bursal disease virus, Inactivated5.50/log 10 50% embryo infective dose0.50millilitre(s)
-
Eggdrop syndrome-1976 virus, Inactivated7.50/log 10 50% embryo infective dose0.50millilitre(s)
-
Newcastle disease virus, Inactivated8.50/log 10 50% embryo infective dose0.50millilitre(s)
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Chicken (layer hen)
-
Eggs0day
-
-
Chicken (for reproduction)
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AA09
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Italian (PDF)
Published on: 3/06/2022